Beta
359679

Antiplatelet therapy and the anaesthetist

Article

Last updated: 29 Dec 2024

Subjects

-

Tags

-

Abstract

Increasing numbers of patients internationally are taking dual antiplatelet therapy (DAPT). Both continuing and stopping this treatment may be risky for the patient. It is vital to consider the competing thrombotic and bleeding risks in the perioperative period. It is incumbent upon anaesthetists to maintain their knowledge base in this rapidly developing area. This article provides information to support practice as.

DOI

10.4103/ejca.ejca_18_18

Keywords

antiplatelet agents, Bleeding, Thrombosis

Authors

First Name

Dina H.

Last Name

Elbarbary

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

13

Article Issue

1

Related Issue

48380

Issue Date

2019-01-01

Receive Date

2018-12-18

Publish Date

2019-01-01

Print ISSN

1687-9090

Online ISSN

2090-326X

Link

https://ejca.journals.ekb.eg/article_359679.html

Detail API

https://ejca.journals.ekb.eg/service?article_code=359679

Order

359,679

Publication Type

Journal

Publication Title

The Egyptian Journal of Cardiothoracic Anesthesia

Publication Link

https://ejca.journals.ekb.eg/

MainTitle

Antiplatelet therapy and the anaesthetist

Details

Type

Article

Created At

20 Dec 2024